Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Change in Receivables (2022 - 2025)

Cardio Diagnostics Holdings' Change in Receivables history spans 4 years, with the latest figure at -$1706.0 for Q3 2025.

  • For Q3 2025, Change in Receivables fell 125.93% year-over-year to -$1706.0; the TTM value through Sep 2025 reached -$2879.0, down 120.94%, while the annual FY2024 figure was $13652.0, 175.24% up from the prior year.
  • Change in Receivables for Q3 2025 was -$1706.0 at Cardio Diagnostics Holdings, down from $3375.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $14028.0 in Q1 2024 and bottomed at -$11468.0 in Q2 2024.
  • The 4-year median for Change in Receivables is $1050.0 (2023), against an average of $938.18.
  • The largest YoY upside for Change in Receivables was 1040.0% in 2024 against a maximum downside of 1192.19% in 2024.
  • A 4-year view of Change in Receivables shows it stood at -$901.0 in 2022, then surged by 611.65% to $4610.0 in 2023, then decreased by 2.13% to $4512.0 in 2024, then crashed by 137.81% to -$1706.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Change in Receivables are -$1706.0 (Q3 2025), $3375.0 (Q2 2025), and -$9060.0 (Q1 2025).